Literature DB >> 26286067

DNA Interaction, Photocleavage and Topoisomerase I Inhibition by Ru(II) Complex with a New Ligand Possessing Phenazine Unit.

Xue-Wen Liu1, You-Ming Shen2, Jun-Shi Shu3, Yang Xiao3, Song-Bai Zhang3, Ji-Lin Lu3.   

Abstract

A new ruthenium complex with a dppz-like ligand pyidppz, [Ru(bpy)2(pyidppz)](2+) (pyidppz = 2-(pyridine-2-yl)imidazo-[4,5-b]dipyrido-[3,2-a:2',3'-c]phenazine) has been synthesized and characterized by ES-MS, elemental analysis, (1)H NMR. Intercalative mode of the complex bound to calf thymus DNA has been supported by different spectroscopic methods and viscosity measurements. The introduction of phenazine unit may be one of the main reasons for the weak emission of Ru(II) complex in aqueous solution. Under irradiation, this complex can efficiently cleave DNA. And the photocleavage reaction of the complex is found to be inhibited in the presence of singlet oxygen scavenger. Topoisomerase inhibition and DNA strand passage assay demonstrated that [Ru(bpy)2(pyidppz)](2+) and its parent complex [Ru(bpy)2(pyip)](2+) (pyip = 2-(pyridine-2-yl)imidazo[4,5-f][1,10]phenanthroline) can act as efficient catalytic inhibitor of DNA topoisomerase I.

Entities:  

Keywords:  DNA-binding; Photocleavage; Ru(II) complex; Topoisomerase inhibition

Mesh:

Substances:

Year:  2015        PMID: 26286067     DOI: 10.1007/s10895-015-1644-8

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  45 in total

1.  Synthesis and DNA-Binding Properties of [Ru(NH(3))(4)dppz](2+).

Authors:  Rajesh B. Nair; Emily S. Teng; Shalawn L. Kirkland; Catherine J. Murphy
Journal:  Inorg Chem       Date:  1998-01-12       Impact factor: 5.165

2.  Turning the [Ru(bpy)2dppz]2+ light-switch on and off with temperature.

Authors:  Matthew K Brennaman; James H Alstrum-Acevedo; Cavan N Fleming; Paul Jang; Thomas J Meyer; John M Papanikolas
Journal:  J Am Chem Soc       Date:  2002-12-18       Impact factor: 15.419

3.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

4.  Potentiation of the novel topoisomerase I inhibitor indenoisoquinoline LMP-400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762.

Authors:  Sheena M Aris; Yves Pommier
Journal:  Cancer Res       Date:  2011-12-21       Impact factor: 12.701

5.  Structure and mechanism of DNA topoisomerase II.

Authors:  J M Berger; S J Gamblin; S C Harrison; J C Wang
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

Review 6.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

7.  Ruthenium(II) complexes of redox-related, modified dipyridophenazine ligands: synthesis, characterization, and DNA interaction.

Authors:  A Ambroise; B G Maiya
Journal:  Inorg Chem       Date:  2000-09-18       Impact factor: 5.165

8.  Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes.

Authors:  Ke-Jie Du; Jin-Quan Wang; Jun-Feng Kou; Guan-Ying Li; Li-Li Wang; Hui Chao; Liang-Nian Ji
Journal:  Eur J Med Chem       Date:  2011-01-21       Impact factor: 6.514

9.  pH- and DNA-induced dual molecular light switches based on a novel ruthenium(II) complex.

Authors:  Yan-Min Chen; Yan-Ju Liu; Qi Li; Ke-Zhi Wang
Journal:  J Inorg Biochem       Date:  2009-08-09       Impact factor: 4.155

10.  Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding.

Authors:  S Satyanarayana; J C Dabrowiak; J B Chaires
Journal:  Biochemistry       Date:  1993-03-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.